Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun 5;2013(6):CD008358.
doi: 10.1002/14651858.CD008358.pub2.

Magnesium for alcohol withdrawal

Michael Sarai  1 , Aaron M Tejani, Alice Hill Wah Chan, I Fan Kuo, Juliana Li
Affiliations

Magnesium for alcohol withdrawal

Michael Sarai et al. Cochrane Database Syst Rev. .

Abstract

Background: Patients have been given magnesium to treat or prevent alcohol withdrawal syndrome (AWS). Evidence to support this practice is limited, and is often based on the controversial link between hypomagnesaemia and AWS.

Objectives: To assess the effects of magnesium for the prevention or treatment of AWS in hospitalised adults.

Search methods: We searched the Cochrane Drugs and Alcohol Group Register of Controlled Trials (August 2012), PubMed (from 1966 to August 2012 ), EMBASE (from 1988 to August 2012), CINAHL (from 1982 to March 2010), Web of Science (1965 to August 2012). We also carried out Internet searches.

Selection criteria: Randomised or quasi-randomised trials of magnesium for hospitalised adults with, or at risk for, acute alcohol withdrawal.

Data collection and analysis: Two review authors independently extracted data with a standardised data extraction form, contacting the correspondence investigator if the necessary information was not available in the reports. Dichotomous outcomes were analysed by calculating the risk ratio (RR) for each trial, with the uncertainty in each result expressed with a 95% confidence interval (CI). Continuous outcomes were to be analysed by calculating the standardised mean difference (SMD) with 95% CI. For outcomes assessed by scales we compared and pooled the mean score differences from the end of treatment to baseline (post minus pre) in the experimental and control groups.

Main results: Four trials involving 317 people met the inclusion criteria. Three trials studied oral magnesium, with doses ranging from 12.5 mmol/day to 20 mmol/day. One trial studied parenteral magnesium (16.24 mEq q6h for 24 hours). Each trial demonstrated a high risk of bias in at least one domain. There was significant clinical and methodological variation between trials.We found no study that measured all of the identified primary outcomes and met the objectives of this review. Only one trial measured clinical symptoms of seizure, delirium tremens or components of the Clinical Institute Withdrawal Assessment for Alcohol (CIWA) score. A single outcome (handgrip strength) in three trials (113 people), was amenable to meta-analysis. There was no significant increase in handgrip strength in the magnesium group (SMD 0.04; 95% CI -0.22 to 0.30). No clinically important changes in adverse events were reported.

Authors' conclusions: There is insufficient evidence to determine whether magnesium is beneficial or harmful for the treatment or prevention of alcohol withdrawal syndrome.

PubMed Disclaimer

Conflict of interest statement

None to declare.

Figures

1
1
Study flow diagram.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
4
4
Forest plot of comparison: 1 Magnesium versus placebo, outcome: 1.1 Muscle strength.
1.1
1.1. Analysis
Comparison 1 Magnesium versus placebo, Outcome 1 Muscle strength.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD008358

References

References to studies included in this review

Aagaard 2005 {published data only}
    1. Aagaard NK, Andersen H, Vilstrup H, Clausen T, Jakobsen J, Dorup I. Magnesium supplementation and muscle function in patients with alcoholic liver disease: a randomized, placebo‐controlled trial. Scandinavian Journal of Gastroenterology 2005;40(8):972‐9. - PubMed
Gullestad 1992 {published data only}
    1. Gullestad L, Dolva LO, Soyland E, Manger AT, Falch D, Kjekshus J. Oral magnesium supplementation improves metabolic variables and muscle strength in alcoholics. Alcoholism, Clinical and Experimental Research. UNITED STATES: Department of Internal Medicine, Baerum Hospital, Sandvika, Norway., 1992; Vol. 16, issue 5:986‐90. - PubMed
Poikolainen 2008 {published data only}
    1. Poikolainen K, Alho H. Magnesium treatment in alcoholics: a randomized clinical trial. Substance Abuse Treatment, Prevention and Policy. England: Finnish Foundation for Alcohol Studies, Helsinki, Finland. kari.poikolainen@stakes.fi., 2008; Vol. 3:1. - PMC - PubMed
Wilson 1984 {published data only}
    1. Wilson A, Vulcano B. A double‐blind, placebo‐controlled trial of magnesium sulfate in the ethanol withdrawal syndrome. Alcoholism, Clinical and Experimental Research 1984;8(6):542‐5. [PUBMED: 6393805] - PubMed

References to studies excluded from this review

Aagaard 2003 {published data only}
    1. Aagaard NK, Andersen H, Vilstrup H, Clausen T, Jakobsen J, Dorup I. Decreased muscle strength and contents of Mg and Na,K‐pumps in chronic alcoholics occur independently of liver cirrhosis. Journal of Internal Medicine 2003;253(3):359‐66. [PUBMED: 12603504] - PubMed
Alexander 1978 {published data only}
    1. Alexander PE, Kammen DP, Bunney WE Jr. Serum calcium and magnesium in schizophrenia: relationship to clinical phenomena and neuroleptic treatment. The British Journal of Psychiatry : the Journal of Mental Science 1978;133:143‐9. [PUBMED: 354732] - PubMed
Avsaroglu 2005 {published data only}
    1. Avsaroglu D, Inal TC, Demir M, Attila G, Acarturk E, Emre Evlice Y, et al. Biochemical indicators and cardiac function tests in chronic alcohol abusers. Croatian Medical Journal 2005;46(2):233‐7. [PUBMED: 15849844] - PubMed
Bardhan 1988 {published data only}
    1. Bardhan KD, Hunter JO, Miller JP, Thomson AB, Graham DY, Russell RI, et al. Antacid maintenance therapy in the prevention of duodenal ulcer relapse. Gut 1988;29(12):1748‐54. [PUBMED: 3065157] - PMC - PubMed
Bjorneboe 1988 {published data only}
    1. Bjorneboe GE, Bjorneboe A, Johnsen J, Skylv N, Oftebro H, Gautvik KM, et al. Calcium status and calcium‐regulating hormones in alcoholics. Alcoholism, Clinical and Experimental Research 1988;12(2):229‐32. [PUBMED: 2837104] - PubMed
Bonkovsky 1991 {published data only}
    1. Bonkovsky HL, Singh RH, Jafri IH, Fiellin DA, Smith GS, Simon D, et al. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. II. Short‐term effects on nitrogen metabolism, metabolic balance, and nutrition. The American Journal of Gastroenterology 1991;86(9):1209‐18. [PUBMED: 1909086] - PubMed
Coetzee 1998 {published data only}
    1. Coetzee EJ, Dommisse J, Anthony J. A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre‐eclampsia. British Journal of Obstetrics and Gynaecology 1998;105(3):300‐3. [PUBMED: 9532990] - PubMed
Colson 1964 {published data only}
    1. Colson JA, Gallay C. Trial treatment of hepatic metabolic disorders by an original formula containing mainly ornithine combined with various classical lipotropic substances [Essai de traitement des dysmetabolies hepatiques par une formule originale comportant pour la premiere fois de l'ornithine associé a diverses substances lipotropes classiques]. Toulouse Medical 1964;65:207‐29. [PUBMED: 14143540] - PubMed
Crews 2001 {published data only}
    1. Crews FT, Braun CJ, Ali R, Knapp DJ. Interaction of nutrition and binge ethanol treatment on brain damage and withdrawal. Journal of Biomedical Science 2001;8(1):134‐42. [PUBMED: 11173987] - PubMed
Deynet 1979 {published data only}
    1. Deynet G, Reimer F. Treatment of alcoholic toxic fatty liver. A placebo‐controlled trial with hepavis (author's transl) [Therapie der alkohol‐toxischen Fettleber. Plazebo‐kontrollierte Doppelblindstudie mit Hepavis.]. MMW, Munchener Medizinische Wochenschrift 1979;121(24):831‐2. [PUBMED: 111085] - PubMed
Dols 1985 {published data only}
    1. Dols W, Verho M, Rangoonwala B, Jaeger S. Piretanide, a potassium stable diuretic, in the treatment of essential hypertension: a double‐blind comparison of two formulations. The Journal of International Medical Research 1985;13(1):31‐9. [PUBMED: 3884409] - PubMed
Enmin 1969 {published data only}
    1. Enmin GM. Features of active anti‐alcohol therapy of patients who have suffered alcoholic psychoses [Osobennosti aktivnogo protivoalkogol'nogo lecheniia bol'nykh perenesshikh ostrye alkogol'nye psikhozy.]. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 1969;69(6):899‐905. [PUBMED: 5364243] - PubMed
Fogarty 2006 {published data only}
    1. Fogarty A, Lewis SA, Scrivener SL, Antoniak M, Pacey S, Pringle M, et al. Corticosteroid sparing effects of vitamin C and magnesium in asthma: a randomised trial. Respiratory Medicine 2006;100(1):174‐9. [PUBMED: 16338599] - PubMed
Gilleran 1996 {published data only}
    1. Gilleran G, O'Leary M, Bartlett WA, Vinall H, Jones AF, Dodson PM. Effects of dietary sodium substitution with potassium and magnesium in hypertensive type II diabetics: a randomised blind controlled parallel study. Journal of Human Hypertension 1996;10(8):517‐21. [PUBMED: 8895035] - PubMed
Gisselman 1982 {published data only}
    1. Gisselmann A, Moyal R, Mollard MA, Marin A. Placebo‐controlled study of a magnesium salt in 48 persons in a postalcoholic treatment center. Revue Alcool 1982;28:63‐74.
Gisselman 1983 {published data only}
    1. Gisselman A, Moyal R, Moard MA, Marin A. Clinical trial of a magnesium compound against placebo in 48 subjects in a post‐cure center for alcoholism. Gazette Medical Francais 1983;90:57‐61.
Grove 1985 {published data only}
    1. Grove O, Bekker C, Jeppe‐Hansen MG, Karstoft E, Sanchez G, Axelsson CK, et al. Ranitidine and high‐dose antacid in reflux oesophagitis. A randomized, placebo‐controlled trial. Scandinavian Journal of Gastroenterology 1985;20(4):457‐61. [PUBMED: 3895381] - PubMed
Hantouche 1998 {published data only}
    1. Hantouche EG, Guelfi JD, Comet D. alpha‐beta L‐aspartate magnesium in treatment of chronic benzodiazepine abuse: controlled and double‐blind study versus placebo [Alpha‐beta L‐aspartate de magnesium dans l'arret de la consommation chronique des benzodiazepines: etude controlee en double aveugle versus placebo.]. L'Encephale 1998;24(5):469‐79. [PUBMED: 9850822] - PubMed
Herpin 1996 {published data only}
    1. Herpin D, Ragot S. Ambulatory blood pressure monitoring: non‐pharmacological and pharmacological treatment. Blood Pressure Monitoring 1996;1(3):241‐5. [PUBMED: 10226236] - PubMed
Herr 2000 {published data only}
    1. Herr DL, Kelly K, Hall JB, Ulatowski J, Fulda GJ, Cason B, et al. Safety and efficacy of propofol with EDTA when used for sedation of surgical intensive care unit patients. Intensive Care Medicine 2000;26 Suppl 4:S452‐62. [PUBMED: 11310908] - PubMed
Hoes 1979 {published data only}
    1. Hoes MJ. The significance of the serum levels of vitamin B‐1 and magnesium in delirium tremens and alcoholism. The Journal of Clinical Psychiatry 1979;40(11):476‐9. [PUBMED: 489530] - PubMed
Hoffmann 2004 {published data only}
    1. Hoffmann K, Schulze MB, Schienkiewitz A, Nothlings U, Boeing H. Application of a new statistical method to derive dietary patterns in nutritional epidemiology. American Journal of Epidemiology 2004;159(10):935‐44. [PUBMED: 15128605] - PubMed
Hornyak 2004 {published data only}
    1. Hornyak M, Haas P, Veit J, Gann H, Riemann D. Magnesium treatment of primary alcohol‐dependent patients during subacute withdrawal: an open pilot study with polysomnography. Alcoholism, Clinical and Experimental Research 2004;28(11):1702‐9. [PUBMED: 15547457] - PubMed
Hristova 1997 {published data only}
    1. Hristova EN, Rehak NN, Cecco S, Ruddel M, Herion D, Eckardt M, et al. Serum ionized magnesium in chronic alcoholism: is it really decreased?. Clinical Chemistry 1997;43(2):394‐9. [PUBMED: 9023146] - PubMed
Iber 1987 {published data only}
    1. Iber FL. Evaluation of an oral solution to accelerate alcoholism detoxification. Alcoholism, Clinical and Experimental Research 1987;11(3):305‐8. [PUBMED: 3307499] - PubMed
Klag 1993 {published data only}
    1. Klag MJ, He J, Whelton PK, Chen JY, Qian MC, He GQ. Alcohol use and blood pressure in an unacculturated society. Hypertension 1993;22(3):365‐70. [PUBMED: 8349329] - PubMed
Lee 2012 {published data only}
    1. Lee KS, Joe KH. Magnesium & acamprosate for the treatment of alcohol withdrawal. Alcoholism, Clinical and Experimental Research 2012;36:296A.
Meyer 1977 {published data only}
    1. Meyer JG, Urban K. Electrolyte changes and acid base balance after alcohol withdrawal, with special reference to rum fits and magnesium depletion. Journal of Neurology 1977;215(2):135‐40. [PUBMED: 68105] - PubMed
Monteiro 1997 {published data only}
    1. Monteiro CP, Varela A, Pinto M, Neves J, Felisberto GM, Vaz C, et al. Effect of an aerobic training on magnesium, trace elements and antioxidant systems in a Down syndrome population. Magnesium Research 1997;10(1):65‐71. [PUBMED: 9339840] - PubMed
Mooney 1985 {published data only}
    1. Mooney A, Cross GM, Cater D, Morgan C. Response to "A double‐blind, placebo‐controlled trial of magnesium sulfate in the ethanol withdrawal syndrome. Alcoholism, Clinical and Experimental Research 1985; Vol. 9, issue 4:384‐5. [PUBMED: 3901811] - PubMed
Murck 1998 {published data only}
    1. Murck H, Steiger A. Mg2+ reduces ACTH secretion and enhances spindle power without changing delta power during sleep in men ‐‐ possible therapeutic implications. Psychopharmacology 1998;137(3):247‐52. [PUBMED: 9683002] - PubMed
Mussalo‐Rauhamaa 1987 {published data only}
    1. Mussalo‐Rauhamaa H, Poikolainen K, Karkkainen P, Lehto J. Decreased serum selenium and magnesium levels in drunkenness arrestees. Drug and Alcohol Dependence 1987;20(2):95‐103. [PUBMED: 3678053] - PubMed
Mutzell 1988 {published data only}
    1. Mutzell S. Cardiovascular and some biochemical effects of high alcohol consumption. Upsala Journal of Medical Sciences 1988;93(3):277‐88. [PUBMED: 3238823] - PubMed
Naderi‐Heiden 2005 {published data only}
    1. Naderi‐Heiden A, Frey R, Presslich O, Frottier P, Willinger U, Blasbichler T, et al. Effect of intravenous magnesium sulphate in reducing irritability and restlessness in pure and polysubstance opiate detoxification. Psychiatry Research 2005;135(1):53‐63. [PUBMED: 15893381] - PubMed
Nowson 1989 {published data only}
    1. Nowson CA, Morgan TO. Magnesium supplementation in mild hypertensive patients on a moderately low sodium diet. Clinical and Experimental Pharmacology and Physiology 1989;16(4):299‐302. [PUBMED: 2663263] - PubMed
Paolisso 1989 {published data only}
    1. Paolisso G, Tirelli A, Coppola L, Verrazzo G, Pizza G, Sgambato S, et al. Magnesium administration reduces platelet hyperaggregability in NIDDM. Diabetes Care 1989; Vol. 12, issue 2:167‐8. [PUBMED: 2702901] - PubMed
Pasternak 2005 {published data only}
    1. Pasternak K, Dabrowski W, Wyciszczok T, Korycinska A, Dobija J, Biernacka J, et al. The relationship between magnesium, epinephrine and norepinephrine blood concentrations during CABG with normovolemic hemodilution. Magnesium Research 2005;18(4):245‐52. [PUBMED: 16548139] - PubMed
Pasternak 2006 {published data only}
    1. Pasternak K, Dabrowski W, Dobija J, Wronskal J, Rzecki Z, Biernacka J. The effect of preoperative magnesium supplementation on blood catecholamine concentrations in patients undergoing CABG. Magnesium Research 2006;19(2):113‐22. [PUBMED: 16955723] - PubMed
Pienaar 1995 {published data only}
    1. Pienaar WP, Roberts MC, Emsley RA, Aalbers C, Taljaard FJ. The thyrotropin releasing hormone stimulation test in alcoholism. Alcohol and Alcoholism 1995;30(5):661‐7. [PUBMED: 8554651] - PubMed
Princi 1997 {published data only}
    1. Princi T, Artero M, Malusa N, Uxa L, Livia V, Reina G. Serum and intracellular magnesium concentrations in intoxicated chronic alcoholic and control subjects. Drug and A lcohol Dependence 1997;46(1‐2):119‐22. [PUBMED: 9246560] - PubMed
Prokop 1970 {published data only}
    1. Prokop L. Studies of the vegetative action mechanism of kavain and magnesium orotate [Untersuchungen zum vegetativen Wirkungsmechaismus von Kavain und Magnesium‐Orotat.]. HNO 1970;18(11):399‐402. [PUBMED: 4933704] - PubMed
Prokop 1971 {published data only}
    1. Prokop L. Studies of the vegetative action mechanism of kavain and magnesium orotate [Untersuchungen zum vegetativen Wirkungsmechanismus von Kavain und Magnesium‐Orotat.]. Wiener Medizinische Wochenschrift (1946) 1971;121(19):399‐402. [PUBMED: 4934590] - PubMed
Pumarino 1996 {published data only}
    1. Pumarino H, Gonzalez P, Oviedo S, Lillo R, Bustamante E. Assessment of bone status in intermittent and continuous alcoholics, without evidence of liver damage [Evaluacion del compromiso oseo en alcoholicos intermitentes y continuos, sin dano hepatico evidente.]. Revista Medica de Chile 1996;124(4):423‐30. [PUBMED: 9110481] - PubMed
Rissanen 1987 {published data only}
    1. Rissanen A, Sarlio‐Lahteenkorva S, Alfthan G, Gref CG, Keso L, Salaspuro M. Employed problem drinkers: a nutritional risk group?. The American Journal of Clinical Nutrition 1987;45(2):456‐61. [PUBMED: 3812344] - PubMed
Ritschel 1970 {published data only}
    1. Ritschel WA, Wagensonner D, Heringer EA. Statistical evaluation of the effect of 3 stimulants of cellular metabolism [Statistische Auswertung uber die Wirksamkeit dreier Zell‐Stoffwechsel‐Stimulantia.]. Schweizerische Rundschau fur Medizin Praxis 1970;59(36):1278‐83. [PUBMED: 5283789] - PubMed
Rouse 1983 {published data only}
    1. Rouse IL, Armstrong BK, Beilin LJ. The relationship of blood pressure to diet and lifestyle in two religious populations. Journal of Hypertension 1983;1(1):65‐71. [PUBMED: 6681026] - PubMed
Schmidt 1994 {published data only}
    1. Schmidt ME, Kruesi MJ, Elia J, Borcherding BG, Elin RJ, Hosseini JM, et al. Effect of dextroamphetamine and methylphenidate on calcium and magnesium concentration in hyperactive boys. Psychiatry Research 1994;54(2):199‐210. [PUBMED: 7761553] - PubMed
Schroder 2004 {published data only}
    1. Schroder H, Marrugat J, Covas M, Elosua R, Pena A, Weinbrenner T, et al. Population dietary habits and physical activity modification with age. European J ournal of Clinical Nutrition 2004;58(2):302‐11. [PUBMED: 14749751] - PubMed
Sherbaniuk 1985 {published data only}
    1. Sherbaniuk RW, Wensel RH, Bailey RJ, Kirdeikis P, Fisher D, Thomson AB. Comparative study of cimetidine and Mylanta II in the 6‐week treatment of gastric ulcer. Journal of Clinical Gastroenterology 1985;7(3):211‐5. [PUBMED: 3894494] - PubMed
Simon 1988 {published data only}
    1. Simon J, Filipovsky J, Rosolova H, Topolcan O, Karlicek V. Cross‐sectional study of beer consumption and blood pressure in middle‐aged men. Journal of Human Hypertension 1988;2(1):1‐6. [PUBMED: 3266252] - PubMed
Singh 1996 {published data only}
    1. Singh RB, Rastogi V, Singh R, Niaz MA, Srivastav S, Aslam M, et al. Magnesium and antioxidant vitamin status and risk of complications of ageing in an elderly urban population. Magnesium Research 1996;9(4):299‐306. [PUBMED: 9247878] - PubMed
Sos 2004 {published data only}
    1. Sos C. Reduction of plasma lactate elevation and proteinuria by a complex dietary supplement in swimmers during over‐loading training. Acta Physiologica Hungarica 2004;91(3‐4):211‐9. [PUBMED: 16438115] - PubMed
Stamler 1997 {published data only}
    1. Stamler J, Caggiula AW, Grandits GA. Relation of body mass and alcohol, nutrient, fiber, and caffeine intakes to blood pressure in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. American Journal of Clinical Nutrition 1997;65(1 Suppl):338S‐65S. [PUBMED: 8988947] - PubMed
Steyn 1986 {published data only}
    1. Steyn K, Jooste PL, Fourie JM, Parry CD, Rossouw JE. Hypertension in the coloured population of the Cape Peninsula. South African Medical Journal 1986;69(3):165‐9. [PUBMED: 3945870] - PubMed
Ueshima 2004 {published data only}
    1. Ueshima K, Tachibana H, Suzuki T, Hiramori K. Factors affecting the blood concentration of ionized magnesium in patients in the acute phase of myocardial infarction. Heart and Vessels 2004;19(6):267‐70. [PUBMED: 15799172] - PubMed
Wheeler 1983 {published data only}
    1. Wheeler MS, Butts JD, Hudson P. Vitreous humor magnesium in alcoholics. The American Journal of Forensic Medicine and Pathology 1983;4(2):105‐10. [PUBMED: 6858995] - PubMed
Zygmunt 2003 {published data only}
    1. Zygmunt M, Heilmann L, Berg C, Wallwiener D, Grischke E, Munstedt K, et al. Local and systemic tolerability of magnesium sulphate for tocolysis. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2003;107(2):168‐75. [PUBMED: 12648863] - PubMed

Additional references

Alonso 2004
    1. ESEMeD/MHEDEA 2000 Investigators. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica. Supplementum 2004;21(7):420. - PubMed
Amato 2011
    1. Amato L, Minozzi S, Davoli M. Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome. Cochrane Database of Systematic Reviews 2011, Issue 6. [DOI: 10.1002/14651858.CD008537] - DOI - PMC - PubMed
Beroz 1962
    1. Beroz E, Conran P, Blanchard RW. Parenteral magnesium in the prophylaxis and treatment of delirium tremens. American Journal of Psychiatry 1962;118:1042‐43. - PubMed
Cochrane Handbook
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Cohen 1988
    1. Cohen J. Statistical power analysis for the behavioral sciences. 2nd Edition. New Jersey: Lawrence Erlbaum Associates, 1988.
Dissanaike 2006
    1. Dissanaike S, Halldorsson A, Frezza EE, Griswold J. An ethanol protocol to prevent alcohol withdrawal syndrome. Journal of the American College of Surgeons 2006;203:186‐91. - PubMed
Embry 1987
    1. Embry CK, Lippmann. Use of magnesium sulphate in alcohol withdrawal. American Family Physician 1987;35:167‐70. - PubMed
Flink 1954
    1. Flink EB, Stutzman FL, Anderson AR, Konig T, Fraser R. Magnesium deficiency after prolonged parenteral fluid administration and after chronic alcoholism complicated by delirium tremens. Journal of Laboratory and Clinical Medicine 1954;43(2):169‐83. - PubMed
Flink 1956
    1. Flink EB. Magnesium deficiency syndrome in man. Journal of the American Medical Association 1956;160:1406‐9. - PubMed
Foy 1995
    1. Foy A, Kay J. The incidence of alcohol‐related problems and the risk of alcohol withdrawal in a general hospital population. Drug and Alcohol Review 1995;14:49‐54. - PubMed
Glickman 1962
    1. Glickman LS, Schenker V, Grolnick S, Green A, Schenker A. Cerebrospinal fluid cation levels in delirium tremens with special reference to magnesium. Journal of Nervous and Mental Disease 1962;134:410‐4. [PUBMED: 13899236] - PubMed
Hasin 2007
    1. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM‐IV alcohol abuse and dependence in the United States. Archives of General Psychiatry 2007;64:830‐42. - PubMed
Higgins 2003
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327(7414):557‐60. - PMC - PubMed
Holsboer 2000
    1. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000;23:477‐501. - PubMed
Jermain 1992
    1. Jermain DM, Drismon ML, Nisbet RB. Controversies over the use of magnesium sulphate in delirium tremens. Annals of Pharmacotherapy 1992;26:650‐2. - PubMed
Martin 1959
    1. Martin HE, McCuskey C, Tupikova N. Electrolyte disturbance in acute alcoholism with particular reference to magnesium. American Journal of Clinical Nutrition 1959;7:191‐6. - PubMed
Mayo‐Smith 1997
    1. Mayo‐Smith MF. Pharmacological management of alcohol withdrawal: a meta‐analysis and evidence‐based practice guideline. JAMA 1997;278:144‐51. - PubMed
Mayo‐Smith 2004
    1. Mayo‐Smith MF, Beecher LH, Fischer TL, Gorelick DA, Guillaume JL, Hill A, et al. Management of alcohol withdrawal delirium: an evidence‐based practice guideline. Archives of Internal Medicine 2004;164:1405‐12. - PubMed
Mays 1970
    1. Mays ET, Ransdell HT, DeWeese BM. Metabolic changes in surgical delirium tremens. Surgery 1970;67(5):780‐8. [PUBMED: 5438679] - PubMed
McKeon 2008
    1. McKeon A, Frye MA, Delanty N. The alcohol withdrawal syndrome. Journal of Neurology, Neurosurgery and Psychiatry 2008;79:854‐862. - PubMed
Mendelson 1959
    1. Mendelson J, Wexler D, Kubzansky P, Leiderman H, Solomon P. Serum magnesium in delirium tremens and alcoholic hallucinosis. Journal of Nervous and Mental Disease 1959;128:352‐7. - PubMed
Mendelson 1969
    1. Mendelson JH, Ogata M, Mello NK. Effects of alcohol ingestion and withdrawal on magnesium status of alcoholics: clinical and experimental findings. Annals of the New York Academy of Sciences 1969;162:918‐33. - PubMed
Murck 2002
    1. Murck H. Magnesium and affective disorders. Nutritional Neuroscience 2002;5:375‐389. - PubMed
Prior 2011
    1. Prior PL, Galduroz JC. Glutamatergic hyperfunctioning during alcohol withdrawal syndrome: therapeutic perspective with zinc and magnesium.. Medical Hypotheses 2011 Sep;77(3):368‐70. - PubMed
Shane 1991
    1. Shane SR, Flink EB. Magnesium deficiency in alcohol addiction and withdrawal. Magnesium and Trace Elements 1991‐1992;10:263‐68. - PubMed
Shulsinger 1977
    1. Shulsinger OZ, Forni PJ, Clyman BB. Magnesium sulfate in the treatment of alcohol withdrawal: a comparison with diazepam. Currents in alcoholism. New York: Grune and Stratton, 1977:319‐27.
Sullivan 1989
    1. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA‐Ar). British Journal of Addiction 1989;84(11):1353‐7. [PUBMED: 2597811] - PubMed
Suter 1955
    1. Suter C, Klingman WO. Neurologic manifestations of magnesium depletion states. Neurology 1955;4:691‐9. - PubMed
Victor 1973
    1. Victor M. The role of hypomagnesaemia and alkalosis to alcohol withdrawal symptoms. Annals of the New York Academy of Sciences 1973;215:235‐48. - PubMed
Vincent 2007
    1. Vincent WR, Smith KM, Winstead PS, Lewis DA. Review of alcohol withdrawal in the hospitalised patient: management. Orthopedics 2007;30:446‐49. - PubMed

Publication types

MeSH terms

LinkOut - more resources